Nimodipine on shuttle-box avoidance learning in mice: No impairment but slight improvement

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 4, 1997, Pages 577-581

  Vetulani, Jerzy ^a   Battaglia, Mario ^b   Sansone, Mario ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b CNR   (Italy)

Author keywords

avoidance learning; mice; nimodipine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIMODIPINE;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AVOIDANCE LEARNING; CALCIUM CHANNEL BLOCKERS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NIMODIPINE;

ANIMALIA;

EID: 0030990630     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00421-2     Document Type: Article

References (27)

1. Antkiewicz-Michaluk L., Romanska I., Michaluk J., Vetulani J Role of calcium channels in effects of antidepressant drugs on responsiveness to pain. Psychopharmacology. 105:1991;269-274.
2. Bovet D., Bovet-Nitti F., Oliverio A. Genetic aspects of learning and memory in mice. Science. 163:1969;139-149.
3. 2+ channel antagonist flunarizine on visual discrimination learning. Neurobiol. Learn. Memory. 64:1995;10-16.
4. Deyo R. A., Panksepp J., Conner R. L. Nimodipine alters acquisition of a visual discrimination task in chicks. Behav. Neural Biol. 53:1990;149-152.
5. Deyo R. A., Straube K. T., Disteroft J. F. Nimodipine facilitates associative learning in aging rabbits. Science. 243:1989;809-811.
6. Finger S., Green L., Tarnoff M. E., Mortman K. D., Andersen A. Nimodipine enhances new learning after hippocampal damage. Exp. Neurol. 109:1990;279-285.
7. Isaacson R. L., Johnston J. E., Vargas D. M. The effect of a calcium antagonist on the retention of simple associational learning. Physiol. Behav. 42:1988;447-452.
8. Izquierdo I. Nimodipine and the recovery of memory. Trends Pharmacol. Sci. 11:1990;309-310.
9. Levy A., Kong R. M., Stillman M. J., Shukitt-Hale B., Kadar T., Rauch T. M., Lieberman H. R. Nimodipine improves spatial working memory and elevates hippocampal acetylcholine in young rats. Pharmacol. Biochem. Behav. 39:1991;781-786.
10. Maurice T., Bayle J., Privat A. Learning impairment following acute administration of the calcium channel antagonist nimodipine in mice. Behav. Pharmacol. 6:1995;167-175.
11. McMonagle-Strucko K., Fanelli R. J. Enhanced acquisition of reversal training in a spatial learning task in rats treated with chronic nimodipine. Pharmacol. Biochem. Behav. 44:1993;827-835.
12. Nikolaev E., Kaczmarek L. Disruption of two-way active avoidance behavior produced by nimodipine. Pharmacol. Biochem. Behav. 47:1994;757-759.
13. Pucilowski O. Psychopharmacological properties of calcium channel inhibitors. Psychopharmacology. 109:1992;12-29.
14. Quartermain D., Hawxhurst A., Ermita B., Puente J. Effect of the calcium channel blocker amlodipine on memory in mice. Behav. Neural Biol. 60:1993;211-219.
15. Sandin M., Jasmin S., Levere T. E. Aging and cognition. Facilitation of recent memory in aged nonhuman primates by nimodipine Neurobiol. Aging. 11:1990;573-575.
16. Sansone M. A further investigation on the effects of chlordiazepoxide given during avoidance training in two inbred strains of mice. Pharmacol. Res. Commun. 11:1979;365-370.
17. Sansone M., Ammassari-Teule M., Oliverio A. Interaction between nootropic drugs and methamphetamine on avoidance acquisition but not on locomotor activity in mice. Arch. Int. Pharmacodyn. Ther. 278:1985;229-235.
18. Sansone M., Battaglia M., Vetulani J. Shuttle-box avoidance behavior of mice treated with nifedipine in combination with nicotine or physostigmine. Pol. J. Pharmacol. 46:1994;169-173.
19. Sansone M., Castellano C., Ammassari-Teule M. Improvement of avoidance acquisition by the nootropic drug oxiracetam in mice. Arch. Int. Pharmacodyn. Ther. 275:1985;86-92.
20. Sansone M., Castellano C., Battaglia M., Ammassari-Teule M. Oxiracetam prevents mecamylamine-induced impairment of active, but not passive, avoidance learning in mice. Pharmacol. Biochem. Behav. 36:1990;389-392.
21. Sansone M., Castellano C., Battaglia M., Ammassari-Teule M. Effects of oxiracetam-nicotine combinations on active and passive avoidance learning in mice. Pharmacol. Biochem. Behav. 39:1991;197-200.
22. Sarter M., Hagan J., Dudchenko P. Behavioral screening for cognition enhancers. From indiscriminate to valid testing: Part II Psychopharmacology. 107:1992;461-473.
23. Scriabine A., Schuurman T., Traber J. Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB J. 3:1989;1799-1809.
24. Sorkin E. M., Clissold S. P., Brogden R. M. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in ischaemic heart disease, hypertension, and related cardiovascular disorders. Drugs. 30:1985;182-274.
25. Vetulani J., Battaglia M., Castellano C., Sansone M. Facilitation of shuttle-box avoidance behaviour in mice treated with nifedipine in combination with amphetamine. Psychopharmacology. 113:1993;217-221.
26. Vetulani J., Sansone M., Bednarczyk B., Hano J. Different effects of 3-chlorophenylpiperazine on locomotor activity and acquisition of conditioned avoidance response in different strains of mice. Naunyn-Schmiedebergs Arch. Pharmacol. 319:1982;271-274.
27. Wolthuis O. L. Behavioural effects of etiracetam in rats. Pharmacol. Biochem. Behav. 15:1981;247-255.